Live Breaking News & Updates on Invo Bioscience

Stay updated with breaking news from Invo bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

INVO Reports Record First Quarter 2024 Financial Results

INVO Reports Record First Quarter 2024 Financial Results
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , Steve Shum , Invo Bioscience Inc , Securities Exchange , Bioscience Inc , Robert Blum Lytham Partners , Biosciences Inc , Record First Quarter , Preferred Stock , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Invo Bioscience , Lytham Partners ,

Short Interest in INVO Bioscience, Inc. (NASDAQ:INVO) Declines By 80.3%

INVO Bioscience, Inc. (NASDAQ:INVO – Get Free Report) was the target of a significant decline in short interest during the month of November. As of November 30th, there was short interest totalling 196,700 shares, a decline of 80.3% from the November 15th total of 997,200 shares. Based on an average daily volume of 3,830,000 shares, […] ....

United States , Virtu Financial , Bioscience Company Profile , Sabby Management , Bioscience Inc , Armistice Capital , Invo Bioscience Inc , Vanguard Group Inc , Get Free Report , Stock Down , Invo Bioscience , Nasdaq Invo ,

Short Interest in INVO Bioscience, Inc. (NASDAQ:INVO) Increases By 397.4%

INVO Bioscience, Inc. (NASDAQ:INVO – Get Free Report) was the target of a significant increase in short interest in October. As of October 31st, there was short interest totalling 289,000 shares, an increase of 397.4% from the October 15th total of 58,100 shares. Based on an average daily volume of 1,840,000 shares, the short-interest ratio […] ....

United States , Bioscience Inc , Armistice Capital , Invo Bioscience Inc , Vanguard Group Inc , Virtu Financial , Bioscience Company Profile , Get Free Report , Invo Bioscience , Nasdaq Invo ,